Skip to main content
QSI logo

Quantum-Si incorporated (QSI) Stock: Price, Forecast & Analyst Target

Quantum-Si incorporated (QSI) — MoonshotScore 28/100 (Weak band), calculated Nov 18, 2026. Price $0.909 (-15.05%), as of the Nov 20, 2026 trading session; market cap $200M.

Listing-status flag — 8-K Item 3.01, filed Jul 24, 2026. Cure deadline stated in filing: Jan 19, 2027.

Educational signal · not a buy or sell recommendation · How to read this

$0.909 −$0.161 (-15.05%) Market Cap $200M

Quantum-Si incorporated · QSI · NASDAQ · Healthcare · Medical - Devices

Research dated 2026-09-13 (results through Q2 FY2026; Q3 FY2026 not covered): Quantum-Si sells a semiconductor-derived platform for detecting individual protein molecules, placing the company closer to an emerging protein-sequencing instrument developer than a conventional medical-device manufacturer. Product adoption remains far too small to absorb the research and commercial cost base. Proteus execution now carries the story: its delayed launch must translate into meaningful demand before persistent cash burn narrows the financing cushion.

Price as of Nov 20, 2026

Key Statistics

28 of 100

MoonshotScore v2 · Quantum-Si (QSI)

Weak
Business Quality Poor (15)
Financial Safety Okay (45)
Valuation Rich (27)
Growth Durability Flat (48)
Momentum Surging (80)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Strong price action running well ahead of the business — bottom-tier quality underneath; a move to treat with suspicion, not chase. The score also carries a risk penalty for losses on top of negative retained earnings. Business Quality: Poor; Financial Safety: Okay; Valuation: Rich; Growth Durability: Flat; Momentum: Surging.

  • quarterly revenue $212,000 (Q3 FY2026, quarter ended Sep 30, 2026)
  • EPS beat 5 of the last 8 reports
  • Altman Z 2.75 · Piotroski F 1

Holding back: weak fundamentals, a rich price

Helping: positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for QSI (58 recorded, newest six shown)
RecordedScoreBand
28Weak
28Weak
28Weak
28Weak
28Weak
28Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$0.909
Change on the day-15.05%
52-week range$0.69–$1.81
Market capitalisation$200M—
Shares traded on the day7.80M
Beta (volatility vs the S&P 500)3.25

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 20, 2026: low $0.712, high $2.29, latest $0.909. 1 other dated event marked. $2.29 $0.712 high $2.29 Jul 23, 2026 · Listing notice · no recorded estimate to compare · close $0.7701 Oct 17, 2025 Nov 20, 2026 · $0.909 $2.28Oct 17, 2025$2.15Oct 31, 2025$1.37Nov 14, 2025$1.41Nov 28, 2025$1.29Dec 12, 2025$1.23Dec 26, 2025$1.22Jan 9, 2026$1.25Jan 23, 2026$1.06Feb 6, 2026$0.941Feb 20, 2026$0.862Mar 6, 2026$0.845Mar 20, 2026$0.748Apr 2, 2026$1.07Apr 17, 2026$0.958May 1, 2026$0.890May 15, 2026$1.19May 29, 2026$0.947Jun 12, 2026$0.855Jun 26, 2026$0.883Jul 10, 2026$0.770Jul 24, 2026$0.814Aug 7, 2026$0.835Aug 21, 2026$0.766Sep 4, 2026$0.745Sep 18, 2026$1.55Oct 2, 2026$1.12Oct 16, 2026$1.46Oct 30, 2026$1.15Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Listing notice

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Other perspectives

Council score for Quantum-Si (QSI): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Negative
Financial Safety Neutral
Valuation Weak
Growth Durability Neutral
Momentum Strong

Legends Council

5 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Favorable read
Englander-style lens (simulated) Izzy Englander Favorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Unfavorable read

Read on: Oct 14, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Negative
Margin of Safety Undervalued
Profit Margin Weak
Revenue Growth Negative
Debt/Equity Strong
ROE Negative
Gross Margin Neutral

Read on: Sep 9, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 9, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is Quantum-Si (QSI), and what does it report?

Short answer · as of

Quantum-Si is developing instruments that apply semiconductor technology to protein sequencing through individual-molecule detection.

Reported revenue is predominantly product sales, with services contributing only a small portion, so the income statement mainly reflects early instrument commercialization rather than a scaled service business. Revenue remains tiny beside research spending and operating losses, making reported growth sensitive to modest changes in product shipments.

2 · Latest results

What do the latest results show for Quantum-Si (QSI)?

Short answer · as of

The most recent reported quarter, Q3 FY2026, carried revenue of $212,000.

The latest period brought a sequential revenue rebound and stronger gross profit, while operating loss widened as research spending increased. Revenue also surpassed the corresponding analyst estimate after a run of misses, but it remained below levels recorded during much of the preceding series. Operating cash outflow improved from the prior period, though the business still consumed far more cash than it generated in sales.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2026$212,000-$22M-$0.10 (diluted)
Q2 FY2026$344,000-$24M-$0.11 (diluted)
Q1 FY2026$258,000-$22M-$0.10 (diluted)
Q4 FY2025$451,000-$18M-$0.08 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Quantum-Si (QSI)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.

Cash and investments substantially exceed debt and liabilities, giving Quantum-Si meaningful room to continue development despite its losses. That protection is eroding: cash and short-term investments have declined materially across the reported window, operating cash flow remains negative, and weak quality screens reflect a business without established earnings support. Management says workforce reductions and expense controls extend funding through the revised Proteus plan, but the delayed launch and a separate Nasdaq listing-status notice make execution and capital preservation inseparable risks.

Data-derived red flags

  • Listing risk — at $0.909 the shares sit below the $1.00 minimum bid NASDAQ requires for continued listing.
  • Negative return on equity (-43.1%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
4 · What to check next?

What should you watch next at Quantum-Si (QSI)?

Short answer · as of

The Nasdaq listing-cure deadline stated in the company's filing is Jan 19, 2027.

Proteus timing is the most consequential operating marker because management moved the planned launch later while tying its funding horizon to the revised schedule. Before launch, watch whether product revenue sustains its recent rebound, gross profit continues to improve, and operating cash outflow falls without another sharp increase in losses. The scheduled earnings release, subsequent periodic filings, and Nasdaq compliance disclosures should clarify whether commercial traction and liquidity remain aligned with management’s plan.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Quantum-Si compare with its peers?

Short answer

Quantum-Si's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Quantum-Si differs from mature medical-device businesses because its core proposition is semiconductor-enabled protein sequencing, not a broad portfolio of established clinical products. Product sales dominate its limited revenue, while research expense and cash consumption still define the financial profile. Cash and investments represent a large share of market value, so comparison with scaled instrument vendors depends less on current sales multiples and more on whether Proteus can move the company from platform development toward repeatable commercialization.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Tactile Systems Technology, Inc. (TCMD) Same industry, near in market value$25.60 Nov 20, 2026$573M90 5-pillar Nov 18, 2026
Viemed Healthcare, Inc. (VMD) Same industry, near in market value$8.52 Nov 20, 2026$323M88 5-pillar Nov 18, 2026
Electromed, Inc. (ELMD) Same industry, near in market value$22.98 Nov 20, 2026$188M87 5-pillar Nov 18, 2026
BrainsWay Ltd. (BWAY) Same industry, near in market value$8.73 Nov 19, 2026$351M87 5-pillar Nov 18, 2026
Illumina, Inc. (ILMN) Named competitor$200.66 Nov 19, 2026$30.3B84 5-pillar Nov 18, 2026
Anika Therapeutics, Inc. (ANIK) Same industry, near in market value$13.23 Nov 20, 2026$177M71 5-pillar Nov 18, 2026
Solana Company (HSDT) Same industry, near in market value$1.49 Nov 20, 2026$93.7M43 5-pillar Nov 18, 2026
Owlet, Inc. (OWLT) Same industry, near in market value$3.23 Nov 19, 2026$96.5M41 5-pillar Nov 18, 2026
Inogen, Inc. (INGN) Same industry, near in market value$5.30 Nov 20, 2026$138M37 5-pillar Nov 18, 2026
Orthofix Medical Inc. (OFIX) Same industry, near in market value$6.07 Nov 20, 2026$247M36 5-pillar Nov 18, 2026
908 Devices Inc. (MASS) Same industry, near in market value$8.67 Nov 20, 2026$361M35 5-pillar Nov 18, 2026
Sight Sciences, Inc. (SGHT) Same industry, near in market value$10.18 Nov 20, 2026$566M34 5-pillar Nov 18, 2026
Quantum-Si (QSI) — this page$0.909$200M28

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$1.90 – $4.00
Consensus target
$2.95
Median target
$2.95

Consensus record · Captured .

Measured against a quoted price of $0.909 (as of Nov 20, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Sep 22, 2026

Transactions
14
Identified insiders
4
Purchases
0
Sales
14
Other transactions
0

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held QSI in their latest 13F filing, and what they did against the filing before it.

InvestorManager13F quarterPortfolio weightValueLast quarter
ARK InvestCathie WoodQ3 20260.05%$7.91MAdded +3.1% shares

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Quantum-Si (QSI)?

Read these with our analysis →

Quantum-Si Healthcare Stock: Key Questions Answered

The last 2 questions are answered from this page's own dated data, not from the research.

Why does the Proteus delay matter for Quantum-Si?

Proteus is the company’s major planned launch, and its revised timing pushes the commercial proof point further out while losses and cash consumption continue. Management says cost reductions support the updated plan, making spending discipline as important as launch execution.

Are Quantum-Si sales mainly products or services?

Product revenue dominates, while services contribute only a small share. The reported sales base therefore depends primarily on early product commercialization rather than a substantial service stream.

Can Quantum-Si fund the revised Proteus plan?

Management says current capital, workforce reductions, and other expense actions can fund operations through the revised plan. Cash and investments remain substantial relative to debt, but continuing operating outflows mean that claim depends on disciplined spending and launch progress.

What does the Nasdaq listing-status notice mean for QSI?

Quantum-Si disclosed that Nasdaq had found its shares out of compliance with the minimum bid-price requirement. The filing provided an initial cure period and a conditional path to additional time; it did not immediately delist the shares. The reviewed terms are historical and do not establish current compliance, so later company disclosures remain necessary.

What is the QSI stock price today?

The last price recorded for Quantum-Si incorporated (QSI), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the QSI price target?

The analyst consensus price target for Quantum-Si incorporated (QSI), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Codex (gpt-5.6-sol) on 2026-09-13. A targeted answer was revised on 2026-10-08 using the source dated on that answer. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 30 figures on this page — 6 from SEC filings and earnings calls, 19 from Financial Modeling Prep (FMP), 4 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-13), by section of the research

  • Summary at the top of the page: Business description; Revenue by segment; Quarterly income statement (USD thousands); Annual revenue and net result (USD millions); Management outlook — dated call excerpts
  • 1. What is Quantum-Si (QSI), and what does it report?: Sector / industry (provider taxonomy); Business description; Revenue by segment; Annual revenue and net result (USD millions); Quarterly income statement (USD thousands)
  • 2. What do the latest results show for Quantum-Si (QSI)?: Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Reported versus estimated, last 8 quarters; Annual revenue and net result (USD millions)
  • 3. What are the financial strengths and risks for Quantum-Si (QSI)?: Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Cash decline over the reported window; Operating cash flow by quarter (USD millions); Distress and quality screens; Management outlook — dated call excerpts; Listing-status notice (8-K Item 3.01)
  • 4. What should you watch next at Quantum-Si (QSI)?: Management outlook — dated call excerpts; Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Next earnings report; Analyst revenue and earnings estimates (average); Most recent periodic reports; Listing-status notice (8-K Item 3.01)
  • 5. How does Quantum-Si compare with its peers?: Business description; Revenue by segment; Annual revenue and net result (USD millions); Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash against market value
  • FAQ: Why does the Proteus delay matter for Quantum-Si?: Management outlook — dated call excerpts; Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash and short-term investments over time (USD millions)
  • FAQ: Are Quantum-Si sales mainly products or services?: Revenue by segment; Business description; Annual revenue and net result (USD millions)
  • FAQ: Can Quantum-Si fund the revised Proteus plan?: Management outlook — dated call excerpts; Cash, investments and debt; Cash and investment components; Operating cash flow by quarter (USD millions); Cash decline over the reported window
  • FAQ: What does the Nasdaq listing-status notice mean for QSI? · Sources (as of 2026-10-08): Listing-status notice (8-K Item 3.01); Recent SEC filings; Quantum-Si Form 8-K Item 3.01 — reviewed initial listing-cure terms · accessed 2026-09-23
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.